Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Founded in 1997, Groupe Nature distributes organic health products, mainly food supplements and cosmetics, through organic specialty shops, pharmacies and online.

Also founded in 1997, Winco is a reference distributor in the French parapharmacy market.

Oaklins’ team in France advised Groupe Nature on the acquisition of Winco.

Service

M&A buy-side

Parties

“We are very proud to integrate Winco into our group and we thank the Oaklins personal care and nutrition team for its commitment and expertise in achieving this transaction, which will allow us to extend our distribution channels to the health food industry and to develop Winco’s health product offering into the organic sector.”

Laurent Ducrocq

CEO, Groupe Nature

Talk to the deal team

Ludovic Beaulieu

Senior Advisor

Paris, France
Oaklins France

View profile Get in touch

Related deals

Armira has signed an agreement to acquire a majority stake in Viabus

Private Equity | Consumer & Retail

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Learn more

EuroHospital Varna has been acquired by Intermedica Group

Healthcare

EuroHospital Varna has been acquired by Intermedica Group

EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.

Learn more

Olyos Group has acquired a controlling stake in NewScience

Healthcare

Olyos Group has acquired a controlling stake in NewScience

Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.

Learn more